AtriCure, Inc. (ATRC) vs Dyne Therapeutics, Inc. (DYN)
A side-by-side comparison of AtriCure, Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRC
AtriCure, Inc.
$54.67HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
DYN
Dyne Therapeutics, Inc.
$15.10HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — ATRC vs DYN
growth of $100 · dividends reinvested · last 6yATRC +36.7% (+5.3%/yr)DYN -35.4% (-7.0%/yr)ATRC compounded faster over this window
ATRC DYN
ATRC vs DYN: by the numbers
- •DYN is the larger company ($2.82B vs $2.78B market cap).
- •ATRC is profitable (1.85% net margin) while DYN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ATRC | DYN |
|---|---|---|
| P/E ratio | 257.64 | N/A |
| P/S ratio | 4.88 | N/A |
| P/B ratio | 5.38 | 4.01 |
| EV / EBITDA | 77.25 | N/A |
| FCF yield | 1.85% | N/A |
Profitability
| Metric | ATRC | DYN |
|---|---|---|
| Gross margin | 76.16% | 0.00% |
| Operating margin | 2.44% | 0.00% |
| Net margin | 1.85% | 0.00% |
| ROE | 2.04% | -73.97% |
| ROIC | 2.04% | -58.28% |
Growth (annualized)
| Metric | ATRC | DYN |
|---|---|---|
| Revenue CAGR (5Y) | 18.57% | N/A |
| Total return CAGR (5Y) | -4.06% | -0.38% |
Frequently asked
- Is ATRC or DYN more profitable?
- ATRC runs the higher net margin — ATRC at 1.85% versus DYN at 0.00%.
- How have ATRC and DYN total returns compared?
- Over the past 5 years, ATRC delivered -4.06% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AtriCure P/E ratioAtriCure ROEDyne Therapeutics ROEAtriCure operating marginDyne Therapeutics operating marginAtriCure revenue growthDyne Therapeutics revenue growthAtriCure free cash flowDyne Therapeutics free cash flow
AtriCure & Dyne Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.